Financial Gravity Asset Management’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History

Financial Gravity Asset Management’s Portfolio LUMO Stock Details LUMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	$3K	Hold	3	–	–	﹤0.01%	1321
2019 Q3	$0	Hold	3	–	–	﹤0.01%	1603
2019 Q2	$0	Hold	3	–	–	﹤0.01%	1725
2019 Q1	$0	Buy	+3	New	+$45	﹤0.01%	1579
2018 Q3	$0	Hold	3	–	–	﹤0.01%	1661
2018 Q2	$0	Hold	3	–	–	﹤0.01%	1645
2018 Q1	$0	Buy	+3	New	+$213	﹤0.01%	1523

Other funds holding LUMO

LPC

Lion Point Capital New York $20.9M AUM 195.52% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $52.8B AUM 58.98% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Financial Gravity Asset Management's LUMO Position: Q4 2019 in Review

Financial Gravity Asset Management held its Lumos Pharma, Inc. Common Stock (LUMO) position steady in Q4 2019 at 3 shares worth $3K. The position accounts for ﹤0.01% of the portfolio, ranked #1321.

Financial Gravity Asset Management first reported a position in LUMO in Q1 2018 and has held it in 7 quarters since. 64 funds tracked by Wall St. Rank hold LUMO as of Q4 2019.

Financial Gravity Asset Management held 3 shares of Lumos Pharma, Inc. Common Stock worth $3K as of Q4 2019.
Financial Gravity Asset Management left its Lumos Pharma, Inc. Common Stock share count unchanged in Q4 2019.
Lumos Pharma, Inc. Common Stock made up ﹤0.01% of Financial Gravity Asset Management's portfolio in Q4 2019, its #1321 holding.
Financial Gravity Asset Management first reported a position in Lumos Pharma, Inc. Common Stock in Q1 2018 and has held it in 7 quarters since.
64 funds tracked by Wall St. Rank held Lumos Pharma, Inc. Common Stock as of Q4 2019.

Based on Financial Gravity Asset Management's 13F filing for Q4 2019, filed 28 Feb 2020.